(3S,6S,9R,12S,15S,23S)-15-[(N-Acetyl-L-norleucyl)amino]-9-benzyl-6-(3-carbamimidamidopropyl)-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotrico sane-23-carboxylic acid acetate (1:1)(CAS: 1607799-13-2)

The compound has a molecular weight of approximately 1234.4 g/mol. It appears as a crystalline solid at room temperature. Solubility data is limited, but it is likely to be soluble in polar organic solvents. The compound is moderately reactive due to its multiple functional groups, including amide, carbamate, and imidazole rings.

The compound is typically synthesized via multi-step reactions involving coupling of indole, amine, and carbamate precursors. Key steps include condensation reactions, amidation, and cyclization. Commonly used catalysts include organometallic reagents and solid-phase synthesis techniques.

This compound is primarily used in the pharmaceutical industry for its potential as a bioactive molecule. It may also find applications in the development of sensors and materials for their unique functional groups and molecular structure.

Handle the compound in a well-ventilated fume hood. Use appropriate personal protective equipment (PPE) such as gloves and lab coat. Spills should be cleaned up immediately using appropriate absorbent materials. Refer to the Safety Data Sheet (SDS) for detailed handling and disposal information.